We also examined the associations between serum Gal-9 and each of the following: sTIM-3, FABP1, FABP4, and the NAFLD severity estimated by abdominal sonography in RA patients. Here, LGALS9 is linked to metabolic dysfunction-associated steatotic liver disease.